com
Pasal sejarah:
Objek dari penelitian ini adalah untuk mengembangkancepat
Diterima 11 November 2017
dan direproduksi dipercepat in vitro metode rilisuntuk
Revisi 3 Mei 2018
memprediksi dan menyimpulkan fungsi nyata waktu (37 °C) rilis
Diterima 17 Mei 2018 Tersedia secara online xxx
untuk mikroglena PLGA kerja panjang. Metode ini dapat
dijelaskan dalam beberapa langkah. Pertama, pelepasan
Kata kunci: mikrosfer dipelajari menggunakan sampel dan metode terpisah
Panjang bertindak PLGA Microspheres pada 37 °C dengan gemetar orbital normal dan suhu tinggi
Peningkatan suhu Persamaan Korsmeyer-Peppas Fungsi Weibull dengan pengadukan magnet untuk lebih mempercepat
pelepasan. Kedua, profil yang paling mirip pada suhu tinggi
dengan rilis real time dipilih dengan bantuan n nilai dalam
Fungsi Korsmeyer-Peppas yang dipasang. Ketiga, fungsi Weibull
dan rasio konversi digunakan untuk menyimpulkan fungsi rilis
real time sesuai dengan profil yang dipilih pada suhu tinggi. Titik
kunci dalam penelitian ini adalah untuk menyediakan metode
cepat dan tepat untuk memprediksi rilis real time untuk
progesteron PLGA mikrosfer progesteron panjang. Jadi suhu
yang tinggi ditambah dengan cincin stir- magnetik digunakan
untuk mempercepat rilis lebih lanjut, dan ketika ada memiliki
banyak profil rilis yang sama dengan waktu rilis nyata pada suhu
tinggi, melepaskan waktu pada temperatur tinggi dan R 2 dari
dideduksi akhir fungsi akan digunakan untuk membantu
memilih profil rilis yang paling mirip dengan rilis real time.
Empat jenis progesteron mikrosfer PLGA digunakan untuk
memverifikasi metode, dan semua fungsi yang disimpulkan
berkorelasi dengan baik dengan rilis real time, untuk R2 =
0,9912, 0,9781, 0,9918 dan 0,9972, masing-masing.
© 2018 Universitas Farmasi Shenyang.
Diterbitkan oleh Elsevier BV Ini
adalah artikel akses terbuka di
bawah lisensi CC BY-NC-ND.
(http://creativecommons.org/lic enses/by-nc-nd/4.0/)
dan sudah ada sudah banyak produk di pasar [1-3]. Salah satu
generalisasi produk adalah bahwa masing-masing memiliki durasi
1. Pendahuluan
aksi yang panjang, yang berkisar dari minggu hingga beberapa
bulan [4–7]. Namun, generalitas ini tidak hanya sangat
Poly (lactic-co-glycolic acid) (PLGA) mikrosfer sebagai sistem rilis
meningkatkan kepatuhan pasien [8] tetapi juga membawa
berkelanjutan tradisional telah dipelajari secara mendalam
∗
Penulis yang sesuai. Shenyang Pharmaceutical University, 103 Wenhua Road, 110016 Shenyang, China. Tel .: +86 24 43520533.
Alamat e-mail: yangxg123@163.com (X. Yang), pppwwwsss@163.com (W. Pan). Ulasan
rekan di bawah tanggung jawab Universitas Farmasi Shenyang.
https://doi.org/10.1016/j.ajps.2018.05.010
1818-0876 / © 2018 Universitas Farmasi Shenyang. Diterbitkan oleh Elsevier BV Ini adalah artikel akses terbuka di bawah lisensi CC BY-NC-ND.
(http://creativecommons.org/licenses/by-nc-nd/4.0/)
2 Asian Journal of Pharmaceutical Sciences 000 (2018) 1–11
2.1. Bahan
2.2. Metode
Table 3 – The intrinsic viscosity of PLGA and the release medium of the microspheres.
Temperatur (°C) k n R2
Gambar. 1 - SEM mikrosfer progesteron-PLGA. (A) Etil format-progesteron-PLGA (RG653H, Evonik) mikrosfer, (B) Etil format-
progesteron-PLGA (65:35, Daigang) mikrosfer, (C) Metilena
klorida-progesteron-PLGA (65:35, Daigang) mikrosfer, (D) Metilen klorida-progesteron-PLGA (75:25, Daigang) mikrosfer.
Tabel 5 - Penjelasan asal-usul fase yang diamati selama pelepasan obat [33].
- - -
Suhu(°C) k n R
2 37
0,0
455
3
0,45
64
0,9
930
43
0,24
70
0,27
90
- - -
Suhu(°C) k n R
2 37
0,02583
0,4902
0,9873
45
0,2659
0,2074
- - -
mixed and tested to help verify the reproducibility of the pre- dicting
release rates [30]. So the very final part of the real time release
method.
was not perfectly described by the deduced function. But this
Luckily, from these results, even with different kinds of drug
method was still a great choice to predict and deduce the func-
loading rate, particle size distribution, different release medium and
tion of real time release in general. It also provided an inspi-
different preparing method with different types of PLGA, the shape
ration in predicting the release profile of long acting micro-
of the release profiles were similar, and there were many other
spheres.
literatures [35–37] deeply studied the
progesterone-PLGA microspheres with many different param-
eters, and they all exhibited the similar shape of the release profile as Declaration of interest
mentioned in this study. In all, the reproducibil- ity of the predicting
method was great, and this method could be a potential good choice No conflict of interest exits in the manuscript, and the article is
to predict the real time re- lease. approved by all the authors.
However, the method still has some shortcomings and it
references
could be seen in figures describing the correlation between the
deduced function and the real time release. The final part of
the profile of the real time release didn't show perfect corre- lation
[1] Han B, Gao SZ, Zhang XH, Tian HB, Wang HT, Shang ZH.
with the deduced function. In the very final part, the microspheres Preparation of aclarubicin PLGA nanospheres and related in
were already ruptured because of the bulk ero- sion, so it could not vitro/in vivo studies. J Appl Polym Sci 2010;398(1–2):130–6.
release drugs in the controlled manner which was the same with the [2] Murata N, Takashima Y, Toyoshima K, Yamamoto M, Okada
former part. H. Anti-tumor effects of anti-VEGF siRNA encapsulated with
PLGA microspheres in mice. J Control Release
In addition, the Weibull function could only be used to describe
2008;126(3):246–54.
erosion-dominated process coupled with minimal diffusive release
[3] Okada H. One- and three-month release injectable microspheres
rates. So, the method in this study couldn't perfectly describe the of the LH-RH superagonist leuprorelin acetate. Adv Drug Delver
very final part of the profiles, but it can successful describe the Rev 1997;28(1):43–70.
profile in general. [4] Mitragotri S, Burke PA, Langer R. Overcoming the challenges in
administering biopharmaceuticals: formulation and delivery
strategies. Nat Rev Drug Discov 2014;13(9):655.
4. Conclusion [5] Wright JC, Burgess DJ. Long acting injections and implants.
US: Springer; 2012. p. 11–24.
The method of elevated temperatures coupled with magnetic stirring [6] Mao SR, Guo CQ, Shi Y, Li LC. Recent advances in polymeric
microspheres for parenteral drug delivery–part 1. Expert Opin
to predict real time release from long acting proges- terone PLGA
Drug Del 2012;9(9):1161–76.
microspheres could be described briefly in sev- eral steps. First, [7] Hoffman AS. The origins and evolution of “controlled” drug
obtain release profiles at 37 °C with orbital shaking and elevated delivery systems. J Control Release 2008;132(3):153–63.
temperatures with magnetic stirring. Second, the Korsmeyer-Peppas [8] Martinez MN, Rathbone MJ, Burgess D, Huynh M. Breakout
equation was used to depict the release profiles at different session summary from AAPS/CRS joint workshop on critical
temperatures to help finding the most similar release profiles from variables in the in vitro and in vivo performance of parenteral
sustained release products. J Control Release 2010;142(1): 2–7.
the elevated tempera- tures with the profile of real time release.
[9] Andhariya JV, Shen J, Choi S, Wang Y, Zou Y, Burgess DJ.
Third, the Weibull function was used to describe the chosen elevated Development of in vitro-in vivo correlation of parenteral
tempera- ture, and the function of the real time release (37 °C) was naltrexone loaded polymeric microspheres. J Control Release
cal- culated with the help of Weibull function and conversion ratio. 2017;255:27–35.
With the use of this method, the function of the real time re- lease [10] Larsen C, Larsen SW, Jensen H, Yaghmur A, Ostergaard J. Role
could be easily deduced according to the release profile at elevated of in vitro release models in formulation development and quality
control of parenteral depots. Expert Opin Drug Del
temperatures.
2009;6(12):1283–95.
Different types of PLGA (RG653H (Evonik), 65:35(0.386, [11] Burgess DJ, Hussain AS, Ingallinera TS, Chen ML. Assuring
Daigang), 75:25 (0.401, Daigang)) and different organic phases quality and performance of sustained and controlled release
(ethyl formate and methylene chloride) were used to make the parenterals: workshop report. Pharm Res 2002;4(2):13–23.
progesterone PLGA microspheres with different drug load- ing rate, [12] D'Souza SS, Faraj JA, Deluca PP. A model-dependent
particle size distribution and even different release mediums were approach to correlate accelerated with real-time release
from biodegradable microspheres. AAPS PharmSciTech
used to help verify the predicting method. All the deduced functions
2005;6(4):E553–64.
exhibited a great correlation with the [13] Zolnik BS, Leary PE, Burgess DJ. Elevated temperature
profile of the real time release in this study with R2 = 0.9912, accelerated release testing of PLGA microspheres. J Control
0.9781, 0.9918 and 0.9972, respectively. Release 2006;112(3):293–300.
However, this elevated temperatures predicting method has [14] Shen J, Burgess DJ. Accelerated release testing methods for
extended-release parenteral dosage forms. J Pharm Pharmacol
limitations. Because the Weibull function was only suit- able for
2012;64(7):986–96.
sigmoidal drug release profiles, and it was used to model release [15] Siewert M, Dressman J, Brown CK, Shah VP, Aiache J, Aoyagi
profiles that showed zero to minimal initial burst release, zero to N, et al. FIP/AAPS guidelines to dissolution/in vitro release
minimal diffusion-mediated release rate or erosion-dominated testing of novel/special dosage forms. AAPS PharmSciTech
process coupled with minimal diffusive 2003;4(1):43–52.
Asian Journal of Pharmaceutical Sciences 000 (2018) 1–11 11
[16] Shen J, Burgess DJ. Accelerated in-vitro release testing modeling of drug release from controlled release tablets. 2003.
methods for extended-release parenteral dosage forms. J [33] Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The
Pharm Pharmacol 2012;64(7):986–96. mechanisms of drug release in poly(lactic-co-glycolic acid)-
[17] Janagam DR, Wang L, Ananthula S, Johnson JR, Tao LL. An based drug delivery systems-A review. Int J Pharm
accelerated release study to evaluate long-acting contraceptive 2011;415(1–2):34–52.
Levonorgestrel-containing in situ forming depot systems. [34] Mollo AR, Corrigan OI. Effect of poly-hydroxy aliphatic ester
Pharmaceutics 2016;8(3):28. polymer type on amoxycillin release from cylindrical compacts.
[18] Shen J, Lee K, Choi S, Wen Q, Wang Y, Burgess DJ. A Int J Pharm 2003;268(1–2):71–9.
reproducible accelerated in vitro release testing method for [35] Acharya G, Shin CS, Vedantham K, Mcdermott M, Rish T,
PLGA microspheres. Int J Pharm 2016;498(1–2):274–82. Hansen K, et al. A study of drug release from homogeneous
[19] Zolnik BS, Leary PE, Burgess DJ. Elevated temperature PLGA microstructures. J Control Release 2010;146(2):201–6.
accelerated release testing of PLGA microspheres. J Control [36] Wu XS. Synthesis, characterization, biodegradation, and drug
Release 2006;112(3):293–300. delivery application of biodegradable lactic/glycolic acid polymers:
[20] Sah H. Microencapsulation techniques using ethyl acetate as a part III. Drug delivery application. Artif Cells Blood Substit
dispersed solvent: effects of its extraction rate on the characteristics Immob Biotechnol 2004;32(4):575–91.
of PLGA microspheres. J Control Release 1997;47(3):233–45. [37] Turino LN, Mariano RN, Mengatto LN, Luna J A. In vitro
[21] Sah H, Smith MS, Chern RT. A novel method of preparing PLGA evaluation of suspoemulsions for in situ-forming polymeric
microcapsules utilizing methylethyl ketone. Pharm Res microspheres and controlled release of progesterone. J
1996;13(3):360–7. Microencapsul 2015;32(6):538–46.
[22] Sah H. Ethyl formate - alternative dispersed solvent useful in [38] Baggi RB, Kilaru NB. Calculation of predominant drug release
preparing PLGA microspheres. Int J Pharm 2000;195(1–2):103–13. mechanism using Peppas-Sahlin model, Part-I (substitution
[23] Liu D, Ichikawa H, Cui F, Fukumori Y. Short-term delayed- method): a linear regression approach. Asian J Pharm Technol
release microcapsules spraycoated with acrylic terpolymers. 2016;6(4):223–30.
Int J Pharm 2006;307(2):300–7. [39] Loo SC, Tan ZY, Chow YJ, Lin SL. Drug release from irradiated
[24] Guse C, Koennings S, Kreye F, Siepmann F, Goepferich A, PLGA and PLLA multi-layered films. J Pharm Sci
Siepmann J. Drug release from lipid-based implants: elucidation 2010;99(7):3060–71.
of the underlying mass transport mechanisms. Int J Pharm [40] Alexis F, Venkatraman SS, Rath SK, Boey F. In vitro study of
2006;314(2):137–44. release mechanisms of paclitaxel and rapamycin from drug-
[25] D'Souza SS, Deluca PP. Methods to assess in vitro drug incorporated biodegradable stent matrices. J Control Release
release from injectable polymeric particulate systems. 2004;98(1):67–74.
Pharm Res 2006;23(3):460–74. [41] Johnson OFL, Jaworowicz W, Cleland JL, Bailey L, Charnis M,
[26] Ritger PL, Peppas NA. A simple equation for description of Duenas E, et al. The stabilization and encapsulation of human
solute release II. Fickian and anomalous release from swellable growth hormone into biodegradable microspheres. Pharm Res
devices. J Control Release 1987;5(1):37–42. 1997;14(6):730–5.
[27] Huang X, Lowe TL. Biodegradable thermoresponsive hydrogels for [42] Duvvuri S, Gaurav JK, Mitra AK. Effect of polymer blending on
aqueous encapsulation and controlled release of hydrophilic model the release of ganciclovir from PLGA microspheres. Pharm Res
drugs. Biomacromolecules 2005;6(4):2131–9. 2006;23(1):215–23.
[28] Siewert M, Dressman J, Brown CK, Shah VP, Aiache JM, [43] Capan Y, Jiang G, Giovagnoli S, Na KH, Deluca PP. Preparation
Aoyagi N, et al. FIP/AAPS guidelines to dissolution/in vitro and characterization of poly(D,L-lactide-co-glycolide)
release testing of novel/special dosage forms. AAPS microspheres for controlled release of human growth hormone.
PharmSciTech 2003;4(1):43–52. AAPS PharmSciTech 2003;4(2):147–56.
[29] Arifin DY, Lai YL, Wang CH. Mathematical modeling and [44] Chen X, Ooi CP, Lim TH. Effect of ganciclovir on the
simulation of drug release from microspheres: implications to hydrolytic degradation of poly(lactide-co-glycolide)
drug delivery systems. Adv Drug Delver Rev 2006;58(12):1274– microspheres. J Biomater Appl 2006;20(3):287–302.
325. [45] Xu Q, Czemuszka J. Controlled release of amoxicillin from
[30] Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use hydroxyapatite-coated poly(lactic-co-glycolic acid)
of the Weibull function for discernment of drug release microspheres. J Control Release 2008;127(2):146–53.
mechanisms. Int J Pharm 2006;309(1-2):44–50. [46] Janoria KG, Mitra AK. Effect of lactide/glycolide ratio on the in
[31] Costa P, Lobo JMS. Modeling and comparison of dissolution vitro release of ganciclovir and its lipophilic prodrug (GCV-
profiles. Eur J Pharm Sci 2001;13(2):123–33. monobutyrate) from PLGA microspheres. Int J Pharm
[32] Alkhatib, Samirsakr H, Adel. Application of the gompertz 2007;338(1–2):133–41.
exponential growth and Korsmeyer-Peppas equations in the [47] Lao L, Venkatraman S, Peppas N. Modeling of drug release from
biodegradable polymer blends. Eur J Pharm Biopharm
2008;70(3):796–803.